Wang Yong Yang

Title: Innovations in Cancer Treatment: The Work of Wang Yong Yang

Introduction

Wang Yong Yang is an accomplished inventor based in Tallahassee, Florida. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing advanced reagents for DNA cleavage, which have the potential to enhance cancer therapies.

Latest Patents

Wang Yong Yang holds a patent for "C-lysine conjugates as pH-controlled, light-activated reagents for double stranded DNA cleavage and associated methods." This patent describes compounds and methods that utilize light-activated lysine conjugates to achieve double-stranded DNA cleavage. The invention is particularly effective at slightly acidic pH levels, which are suitable for selectively targeting cancer cells. The presence of two amino groups with different basicities enhances the solubility and affinity of the compounds to DNA. The protonation of the second amino group at the desired pH threshold leads to increased DNA-cleaving ability, making these molecules promising candidates for phototherapy in cancer treatment.

Career Highlights

Wang Yong Yang is affiliated with the Florida State University Research Foundation, Inc. His research has garnered attention for its innovative approach to cancer treatment, and he continues to explore new methodologies to improve therapeutic outcomes for patients.

Collaborations

Wang Yong Yang has collaborated with notable researchers in his field, including Igor Alabugin and Serguei V Kovalenko. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Wang Yong Yang's innovative work in the field of cancer treatment exemplifies the potential of scientific research to improve patient outcomes. His patented inventions represent a significant step forward in the development of targeted therapies for cancer.